TScan Therapeutics
TCRX
TCRX
66 hedge funds and large institutions have $272M invested in TScan Therapeutics in 2024 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 22 increasing their positions, 9 reducing their positions, and 5 closing their positions.
Holders
66
Holders Change
+12
Holders Change %
+22.22%
% of All Funds
0.96%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
17
Increased
22
Reduced
9
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Invesco
Atlanta,
Georgia
|
$3.88M |
| 2 |
LCM
2
Laurion Capital Management
New York
|
$2.88M |
| 3 |
3
Millennium Management
New York
|
$3.11M |
| 4 |
4
Goldman Sachs
New York
|
$2.07M |
| 5 |
TAM
5
Tocqueville Asset Management
New York
|
$1.68M |
